Literature DB >> 24771908

Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.

A Waldmann1, N Eisemann2, A Katalinic3.   

Abstract

Cervical, uterine and ovarian cancers are the most common malignancies of the female genital tract. Using current data from population-based cancer registries in Germany, we present the recent figures for the incidence, prevalence, associated mortality and survival for these cancers. In 2009, a total of 23 800 women were newly diagnosed with one of the three gynaecological cancers (cervical cancer: 20.3 %, endometrial cancer: 48.5 %, ovarian cancer: 31.2 %). This figure equals approximately one third of the number of women newly diagnosed with breast cancer in the same year. The relative 5-year survival for carcinomas of the corpus uteri is 79 % and is higher that those for cervical cancer (68 %) and ovarian cancer (40 %). Ovarian cancer in particular is often diagnosed at a later stage and has a high risk of recurrence. Due to the favourable prognosis for endometrial tumours and the unfavourable prognosis for ovarian malignancies, the incidence of various gynaecological tumours is ranked differently compared to the 5-year prevalence of these same tumours. Currently, the 5-year prevalence in Germany for patients with cervical, endometrial or ovarian cancer is estimated to be around 80 000 women. Slightly more than half of these women were diagnosed with cancer of the corpus uteri. Around 25 % of women have ovarian and 21 % have cervical cancer.

Entities:  

Keywords:  cervical cancer; endometrial cancer; epidemiology; ovarian cancer

Year:  2013        PMID: 24771908      PMCID: PMC3859169          DOI: 10.1055/s-0032-1328266

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  9 in total

1.  Human papillomavirus and cervical cancer: burden of illness and basis for prevention.

Authors:  Helen Trottier; Eduardo L Franco
Journal:  Am J Manag Care       Date:  2006-12       Impact factor: 2.229

2.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

Review 3.  Endometrial cancer.

Authors:  Frederic Amant; Philippe Moerman; Patrick Neven; Dirk Timmerman; Erik Van Limbergen; Ignace Vergote
Journal:  Lancet       Date:  2005 Aug 6-12       Impact factor: 79.321

4.  Importance of HPV Genotyping for the Screening, Therapy and Management of Cervical Neoplasias.

Authors:  M Jentschke; P Soergel; P Hillemanns
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-06       Impact factor: 2.915

5.  Diabetes increases the risk of breast cancer: a meta-analysis.

Authors:  Prue J Hardefeldt; Senarath Edirimanne; Guy D Eslick
Journal:  Endocr Relat Cancer       Date:  2012-11-19       Impact factor: 5.678

6.  Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.

Authors:  Henrike E Karim-Kos; Esther de Vries; Isabelle Soerjomataram; Valery Lemmens; Sabine Siesling; Jan Willem W Coebergh
Journal:  Eur J Cancer       Date:  2008-02-14       Impact factor: 9.162

7.  Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix--worldwide.

Authors:  Aleyamma Mathew; Preethi Sara George
Journal:  Asian Pac J Cancer Prev       Date:  2009 Oct-Dec

8.  Survival of cervical cancer patients in Germany in the early 21st century: a period analysis by age, histology, and stage.

Authors:  Tianhui Chen; Lina Jansen; Adam Gondos; Katharina Emrich; Bernd Holleczek; Sabine Luttmann; Annika Waldmann; Hermann Brenner
Journal:  Acta Oncol       Date:  2012-08-29       Impact factor: 4.089

Review 9.  The epidemiology of human papillomavirus infection and cervical cancer.

Authors:  F Xavier Bosch; Silvia de Sanjosé
Journal:  Dis Markers       Date:  2007       Impact factor: 3.434

  9 in total
  16 in total

Review 1.  Chemoresistance and targeting of growth factors/cytokines signalling pathways: towards the development of effective therapeutic strategy for endometrial cancer.

Authors:  Fengjun Guo; Haina Zhang; Zanhui Jia; Manhua Cui; Jingyan Tian
Journal:  Am J Cancer Res       Date:  2018-07-01       Impact factor: 6.166

2.  circ_0025033 promotes ovarian cancer development via regulating the hsa_miR-370-3p/SLC1A5 axis.

Authors:  Huiping Ma; Shuyun Qu; Yao Zhai; Xiaofeng Yang
Journal:  Cell Mol Biol Lett       Date:  2022-10-22       Impact factor: 8.702

3.  Use of Laparoscopy in the Treatment of Endometrial and Cervical Cancer - Results of a 2012 Germany-wide Survey.

Authors:  I Juhasz-Böss; P Mallmann; C P Möller; E F Solomayer
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-09       Impact factor: 2.915

4.  Postoperative Health-Related Quality of Life of Cervical Cancer Patients - A Comparison between the Wertheim-Meigs Operation and Total Mesometrial Resection (TMMR).

Authors:  E Sowa; S Kuhnt; A Hinz; C Schröder; T Deutsch; K Geue
Journal:  Geburtshilfe Frauenheilkd       Date:  2014-07       Impact factor: 2.915

5.  Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.

Authors:  Stefanie Burghaus; Lothar Häberle; Michael G Schrauder; Katharina Heusinger; Falk C Thiel; Alexander Hein; David Wachter; Johanna Strehl; Arndt Hartmann; Arif B Ekici; Stefan P Renner; Matthias W Beckmann; Peter A Fasching
Journal:  BMC Cancer       Date:  2015-10-21       Impact factor: 4.430

Review 6.  Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.

Authors:  Hsiang-Cheng Chi; Chung-Ying Tsai; Ming-Ming Tsai; Kwang-Huei Lin
Journal:  Int J Mol Sci       Date:  2018-02-12       Impact factor: 5.923

7.  Macrophage capping protein CapG is a putative oncogene involved in migration and invasiveness in ovarian carcinoma.

Authors:  J Glaser; M H D Neumann; Qi Mei; B Betz; N Seier; I Beyer; T Fehm; H Neubauer; D Niederacher; M C Fleisch
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

8.  Incidence and mortality rates in breast, corpus uteri, and ovarian cancers in Poland (1980-2013): an analysis of population-based data in relation to socioeconomic changes.

Authors:  Tomasz Banas; Grzegorz Juszczyk; Kazimierz Pitynski; Dorota Nieweglowska; Artur Ludwin; Aleksandra Czerw
Journal:  Onco Targets Ther       Date:  2016-09-07       Impact factor: 4.147

9.  Anti-cancer effects of Kaempferia parviflora on ovarian cancer SKOV3 cells.

Authors:  Suthasinee Paramee; Siriwoot Sookkhee; Choompone Sakonwasun; Mingkwan Na Takuathung; Pitchaya Mungkornasawakul; Wutigri Nimlamool; Saranyapin Potikanond
Journal:  BMC Complement Altern Med       Date:  2018-06-11       Impact factor: 3.659

10.  Systematic characterization of germline variants from the DiscovEHR study endometrial carcinoma population.

Authors:  Jason E Miller; Raghu P Metpally; Thomas N Person; Sarathbabu Krishnamurthy; Venkata Ramesh Dasari; Manu Shivakumar; Daniel R Lavage; Adam M Cook; David J Carey; Marylyn D Ritchie; Dokyoon Kim; Radhika Gogoi
Journal:  BMC Med Genomics       Date:  2019-05-03       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.